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Early Referral in Chronic Kidney Disease:
More Should be Done
The prevalence of chronic kidney disease (CKD) has
been increasing worldwide [1]. It is estimated that the
global end-stage renal disease (ESRD) population will
exceed 2 million by the year 2010 if the current trend
of ESRD prevalence continues [1]. The aggregated cost
of managing ESRD patients is substantial and can
amount to a huge financial burden on health care
systems around the world, especially on those of
developing countries. Strategies to slow down the
progression of chronic renal disease would be
imperative to ease this burden and to help fight against
this worldwide CKD epidemic.
A report on the consensus statements of the
consensus workshop on prevention of progression of
renal disease was published in 2005 [2] after the
International Society of Nephrology’s Conference on
Prevention of Progression of Renal Disease that was
held in Hong Kong in 2004. The report focused on three
areas, namely: (1) screening for CKD; (2) evaluating
and estimating progression of CKD; and (3) measures
to prevent the progression of renal disease. Fifteen
consensus statements were made in these three areas.
Measures to prevent the progression of CKD, including
lifestyle modification, blood pressure control, glycemic
control, reduction of proteinuria, dietary protein
restriction, lipid lowering, avoidance of nephrotoxic
agents, correction of anemia, management of calcium–
phosphate abnormality, maintenance of fluid balance,
correction of acidosis, and early patient referral to
nephrologists for evaluation, were highlighted in
the report.
Based on the KDOQI guideline, patients with CKD
should be referred to nephrologists for evaluation
when their creatinine clearance is less than 30 mL/min/
1.73 m2, or earlier in patients at risk of rapid progression
or in whom doubt exists as to their diagnosis and
prognosis [3]. An increasing amount of literature
supports the benefit of early intervention of CKD on
long-term outcomes, especially with regard to early
referral to nephrologists. Late referral to a nephrologist
has also been demonstrated to be associated with
greater odds of death after initiation of dialysis [4–8].
Stacks et al showed that the mortality rate was nearly
70% greater for patients referred to nephrologists
within 4 months of initiation of dialysis compared to
patients who were referred earlier [4]. Kinchen et al
demonstrated that the risk of death was greater among
patients who were evaluated late and that this risk
was graded (30% increase for intermediate evaluation,
i.e. 4–12 months, and 80% increase for late evaluation,
i.e. < 4 months, compared to those who had early
intervention, i.e. > 12 months) [5]. Sesso and Belasco
observed a 2.05 adjusted relative risk of death during
the first 6 months of dialysis among patients who were
referred late (< 1 month) compared to those who were
referred early [7]. By using a propensity score analysis
method, Kazmi et al also showed that among patients
with CKD who initiated dialysis, late referral (< 4
months) was associated with a 40% higher risk of death
at 1 year after initiation of dialysis compared to those
with early referral [8].
Different reasons have been postulated for the
improved outcome of ESRD patients who were referred
early to nephrologists for assessment and management
before initiation of dialysis. Firstly, it gives time for
the nephrologists to use measures to halt the progression
of renal disease and to manage the comorbid conditions
associated with CKD. These include the use of
angiotensin converting enzyme inhibitors (ACEI)/
angiotensin receptor blockers (ARB), better blood
pressure control and management of cardiovascular risk
factors, e.g. lipid and glucose abnormalities, correction
of anemia and other metabolic disorders, and to provide
appropriate counseling on renal replacement therapy
(RRT) modality selection and timing for creation of
dialysis access [4]. Secondly, the patients could also
receive pre-dialysis education to enhance their coping
skills and to allow them to have more time for asking
about and to make an informed and shared choice of
dialysis modality. Thirdly, the patients might also be
able to receive appropriate nutritional counseling to
avoid hypoalbuminemia,  hyperkalemia,  and
hyperphosphatemia before dialysis. In this regard,
primary care physicians as well as general physicians
should play an active role in the process of early
intervention. Not only should they be empowered to
recognize when to refer, but also to assist in patient
education, risk factor modification, co-management of
kidney disease and its manifestations [9], and to develop
better communication channels with nephrologists for
better patient care.
In this issue of the Hong Kong Journal of
Nephrology, Chirravoori et al report interesting findings
from a questionnaire survey revealing general
physicians’ views and approaches to CKD in India [10].
One hundred and four general physicians working in
tertiary medical centers in the city of Delhi responded
to the survey. Although most respondents agreed that
Y.H. Chan
46 Hong Kong J Nephrol • October 2006 • Vol 8 • No 2
CKD was likely to become a significant public health
issue in India, only one-fifth of respondents proposed
that early diagnosis would be helpful to control the
epidemic of CKD, and about a quarter believed that
treatment of comorbidities would be remedies to
control the epidemic. In addition, although 63.4% of
respondents felt that they should refer patients to
nephrologists early, less than a few percent actually
managed to do so. About 38.5% of respondents
indicated that serum creatinine is the best marker for
both diagnosis and monitoring of disease progression
of CKD without acknowledging its potential limitation.
Non-availability of services and costs were felt to be
the major constraints in controlling CKD in India.
Clearly, this paper demonstrates that more could be
done to strengthen the knowledge of general physicians
working in developing countries like India on the
concepts as well as on the management of CKD.
When interpreting the results of this study, we
should be aware of the limitations of a population-based
survey. As the questionnaires were only distributed to
doctors working in tertiary medical centers, it might
have understated the problems in the community. Also,
as the questionnaire was a self-administered one and
as most questions were open-ended, answers from some
of the respondents were vague and needed further
clarification. Finally, recall bias is always an issue, and
we have to be careful especially when interpreting the
findings on physicians’ referral attitude and practice.
Delayed referral  to nephrologists  before
commencement of RRT is actually a worldwide
problem. Chirravoori et al found that less than 10% of
patients were seen by nephrologists within 4 months
prior to RRT commencement [10]. Even in the
developed world, the figures for late referral range from
25% to 50% [11]. The causes of delayed referral are
multifactorial [12], and some are unavoidable, for
example, ESRD following acute renal failure,
asymptomatic “renal failure” only presenting at an
advanced stage, or patient’s refusal to seek help until
symptoms are critical. The structure of the health care
system might also influence the pattern of referral. In
areas where there is limited access to quality medical
care, patients would more likely be seen only at the
time of urgent dialysis. However, referral bias and the
attitudes of primary care physicians could have strong
influences on the referral pattern as well [12]. Further
training and education with respect to guidelines
regarding timing of and indications for referral, and
better communication between general physicians,
primary care physicians and nephrologists should help
to improve the situation.
When fighting the CKD epidemic in developing
countries like India where RRT is a luxury, emphasis
should be paid to the detection and slowing of the
progression of kidney disease. National medical
societies should set up guidelines for referral of CKD
patients to nephrologists, and to determine the most
appropriate screening markers for their community.
Education on the natural progression of kidney disease
as well as on the guidelines regarding timing of and
indications for referral should be provided to family
and general physicians. Primary care physicians should
also be engaged in the process of early intervention, in
assisting patient education, and in risk factor
modification, e.g. adequate blood pressure control, use
of ACEI/ARB, reduction of proteinuria, management
of mineral abnormalities and other renal disease
comorbidities. In fact, Mani has reported a successful
program to prevent CKD in India by regular screening
of the community and patients at risk of renal failure
by examining urine for blood and protein, estimating
their GFR using the Modification of Diet in Renal
Disease (MDRD) formula, and to offer treatment for
diabetes and hypertension at the community level using
affordable medicines [13]. The results have been very
gratifying.
More should be done to fight the CKD epidemic,
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